Episurf Medical
0.363 SEK -3.07%1 investor is following this company
Episurf Medical is a medical technology company. The company conducts research and development of products used for the treatment of cartilage damage. Episurf's primary focus is on the recovery of knee joints, but the company's implants can also be applied to other joints. Episurf Medical is in the preclinical verification phase and is headquartered in Stockholm.
Revenue
10.3M
EBIT %
-938.83 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
EPIS B
Daily low / high price
0.363 / 0.374
SEK
Market cap
96.81M SEK
Turnover
57.85K SEK
Volume
156K
Latest videos
Financial calendar
Extraordinary general meeting
22.05.2024
Interim report
12.07.2024
Interim report
25.10.2024
Annual report
07.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Health Runner | 13.0 % | 13.0 % |
Fjärde AP-Fonden | 4.7 % | 4.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Episurf: INTERIM REPORT 1 JANUARY - 31 MARCH 2024
Notice of Extraordinary General Meeting of Episurf Medical AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools